Status:
COMPLETED
Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise
Lead Sponsor:
St. Louis University
Conditions:
Cognitive Enhancement During Exercise
Eligibility:
All Genders
18-60 years
Phase:
EARLY_PHASE1
Brief Summary
This study evaluates the effects of acute huperzine A ingestion prior to exercise on cognitive function and perceived effort in exercise-trained individuals. Huperzine A has shown the ability to impro...
Detailed Description
Huperzine A improves cognitive function by inhibiting the enzyme acetylcholinesterase. This enzyme is responsible for the degradation of the neurotransmitter acetylcholine. inhibition of acetylcholine...
Eligibility Criteria
Inclusion
- Men and women of all ethnic and racial groups that participate in endurance exercise of moderate to vigorous intensity at least three days per week, for at least 20 minutes per session, for at least six months prior to this study
Exclusion
- Anyone not within the age range listed in section 8a will be excluded. Individuals who require medical clearance to participate in vigorous exercise based on ACSM's risk assessment algorithm will be excluded from the study. The participant screening form will be used to identify signs and symptoms or medical conditions that require medical clearance to participate in vigorous exercise.
Key Trial Info
Start Date :
January 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 5 2018
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03445104
Start Date
January 16 2018
End Date
April 5 2018
Last Update
May 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allied Health Professional Building
St Louis, Missouri, United States, 63139